Our Work
Latham & Watkins Advises Turquoise Health on US$40 Million Series C
March 17, 2026
Emerging Companies & Growth team represents the healthcare pricing and payment platform in the financing.
Turquoise Health, a multi‑sided healthcare pricing and payment platform, has announced that it has raised US$40 million in Series C funding. The round was led by Oak HC/FT, with participation from existing investors including Andreessen Horowitz, Adams Street Partners, and Yosemite.
Latham & Watkins LLP advised Turquoise Health in the transaction with an Emerging Companies & Growth team led by Bay Area partner Benjamin Potter and San Diego partner Christian Hollweg, with associate Alex Stuart‑Lovell.